Australia's largest stock trading and investment forum Australia's #1 stock forum

MYX

Click for more information

1.47%

$4.70 mayne pharma group limited

What MYX chart shouts, page-265

First 265 Last

Share
Profile

Follow
newB

7,134 Posts.

546

24/08/24

13:55

Post #: 75355712
Share

Originally posted by KamikazePilot: ↑

Just received an email from Simply Wall St in regard Friday's trading report heading "New major risk - Financial position , reads " The company has less than than a year of cash runaway based on its current free cash flow trend . Fresh cash flow - AUS $36 m This is considered a major risk . With less than a year's worth of cash the company will need to raise capital or take debt unless cash flow improves . This would dilute existing shareholders or increase balance sheet risk . Currently the following risks have been identified for the company . Major risk . Less than a year of runaway based on free cash flow trend (Aus $ 36 m free cash flow). Minor Risk . Currently unprofitable and not forecast to be able to become profitable profitable over the next two years . " This is what has been concerning me ( my last post ) " Company not expected to be profitable minimum 2 maybe 3 years , company reliant on its shareholders most at risk common shareholders us unsecured expected to carry / support management . " Can see a another capital raising coming up with our present management team just as we did back then when we copped capital raising from the last lot when we purchased a truck of generic rubbish off Teva .

Expand

"Simply Wall St"??

MYX Price at posting: $4.38 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

MXR

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 108 more messages in this thread...

First 265 Last

Add MYX (ASX) to my watchlist

(20min delay)
Last $4.70		Change -0.070(1.47%)		Mkt cap ! $393.0M

Open	High	Low	Value	Volume
$4.71	$4.72	$4.61	$220.2K	47.42K

Buyers (Bids)

No.	Vol.	Price($)
1	100	$4.70

Sellers (Offers)

Price($)	Vol.	No.
$4.71	300	1

View Market Depth

No.	Vol.	Price($)
3	317	4.640
5	976	4.630
4	1065	4.620
4	820	4.610
4	1053	4.600

Price($)	Vol.	No.
4.670	641	5
4.680	1311	3
4.690	1198	3
4.700	861	3
4.710	3172	4

Last trade - 12.06pm 02/10/2024 (20 minute delay)

MYX (ASX) Chart

SPONSORED BY